RHEAVITA
RheaVita is a pharmaceutical company developing continuous freeze-drying technology for biopharmaceutical products. The company technology integrates all freeze-drying process step unit operations in a continuous production line with the constant infeed of products and the concomitant outfeed of the dried product. Its manufacturing approach avoids scale-up issues, reduces cycle times, allows fast product development, reduces time-to-market, lowers production costs, makes use of smaller manufacturing installations, requires less clean room space, provides improved quality assurance (100% inspection with inherent potential for real-time-release) and leads to improved and uniform product quality and process uniformity.
RHEAVITA
Industry:
Biopharma Biotechnology Mechanical Engineering Pharmaceutical
Founded:
2018-01-01
Address:
Zwijnaarde, Oost-Vlaanderen, Belgium
Country:
Belgium
Website Url:
http://www.rheavita.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Global Site Tag Euro ReCAPTCHA
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Novalis Biotechnology Incubation
Novalis Biotechnology Incubation investment in Series A - RheaVita
PMV
PMV investment in Series A - RheaVita
Official Site Inspections
http://www.rheavita.com Semrush global rank: 6.16 M Semrush visits lastest month: 1.31 K
- Host name: 5.134.4.217.static.hosted.by.combell.com
- IP address: 5.134.4.217
- Location: Merelbeke Belgium
- Latitude: 51.0015
- Longitude: 3.7433
- Timezone: Europe/Brussels
- Postal: 9820
More informations about "RheaVita"
RheaVita – Continuous Freeze-Drying
RheaVita is currently developing the first continuous freeze-drying system allowing GMP production. In addition, a non-GMP multi-vial system will be made available. Find out how …See details»
About - RheaVita
RheaVita strives to develop and market fundamental improvements for the manufacturing of (bio)pharmaceuticals. This is done through technological developments based upon thorough fundamental research.See details»
RheaVita - Crunchbase Company Profile & Funding
Jun 2, 2021 · RheaVita is a pharmaceutical company developing continuous freeze-drying technology for biopharmaceutical products. The company technology integrates all freeze …See details»
RheaVita - VentureRadar
RheaVita provides continuous freeze-drying technology for (bio)pharmaceutical products resolving the issues and shortcomings related to traditional batch freeze-drying, but also providing new …See details»
RheaVita announces strategic partnership with IMA Life to drive …
Nov 18, 2024 · IMA Life makes a strategic investment in RheaVita and will support the company in advancing and commercializing its breakthrough continuous freeze-drying technology for …See details»
RheaVita - PiLS
RheaVita provides continuous and controlled freeze-drying technology and services for (bio)pharmaceutical products, resolving the issues and shortcomings related to traditional …See details»
RheaVita - Contacts, Employees, Board Members, Advisors & Alumni
RheaVita is a pharmaceutical company developing continuous freeze-drying technology for biopharmaceutical products.See details»
RheaVita Closes EUR 2.5 million Series A Financing Co …
Jun 2, 2021 · RheaVita has developed the world’s first end-to-end continuous freeze-drying solution to address biopharmaceutical product development, manufacturing and supply needs in order to efficiently...See details»
IMA Life, part of the IMA Group, announces strategic partnership …
Nov 19, 2024 · IMA Life makes a strategic investment in RheaVita and will support the company in advancing and commercializing its breakthrough continuous freeze-drying technology for …See details»
IMA Life and RheaVita team up to commercialise continuous ...
Nov 18, 2024 · RheaVita has joined forces with IMA Life to develop and commercialise RheaVita's continuous biopharmaceutical freeze drying technology. Through the partnership, RheaVita …See details»
Coriolis Pharma and RheaVita join forces in collaboration for ...
Jul 31, 2023 · _Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities …See details»
Rheavita - PMV
Rheavita is pioneering freeze-drying technology for pharmaceutical products. Many drugs today are freeze-dried to ensure sufficient stability during distribution and storage, avoiding the use …See details»
RheaVita Closes EUR 2.5 million Series A Financing Co-Led by …
Ghent, Belgium, June 2, 2021 – RheaVita, a company pioneering continuous freeze-drying technology for biopharmaceutical products, announced today that the company has closed a …See details»
RheaVita Announces Strategic Partnership With IMA Life, Part of …
Nov 18, 2024 · IMA Life makes a strategic investment in RheaVita and will support the company in advancing and commercializing its breakthrough continuous freeze-drying technology for …See details»
RheaVita Closes EUR 2.5 million Series A Financing Co-Led by …
Jun 8, 2021 · RheaVita has developed the world’s first end-to-end continuous freeze-drying solution to address biopharmaceutical product development, manufacturing and supply needs …See details»
RheaVita Announces Strategic Partnership With IMA Life, Part of …
Nov 18, 2024 · RheaVita, a pioneer in controlled, continuous freeze-drying technology for biopharmaceuticals, is pleased to announce a strategic partnership with IMA Life, one of the …See details»
Benefits - RheaVita
Rheavita respects your privacy. You can unsubscribe at any time. Email. CAPTCHA. TECHNOLOGY. Concept SVU Products GMP-Flex PAT Intellectual Property. ABOUT …See details»
Technology - RheaVita
The RheaVita Continuous Freeze-Drying Technology is based on spinning the vials while cooling and freezing making use of cold gas, resulting in a thin product layer spread over the inner vial …See details»
IMA Life, Part of the IMA Group, Announces Strategic Partnership …
Nov 21, 2024 · IMA Life, one of the three pharma divisions of IMA Group and global leader in advanced, aseptic pharmaceutical process and production solutions, announces a strategic …See details»
News - RheaVita
Nov 13, 2024 · RheaVita announces strategic partnership with IMA Life. RheaVita is one of the winners of the CPHI Pharma Awards 2024. We won in the category “Manufacturing …See details»